Multi-state engagement with continuous glucose monitoring systems

US11696706B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11696706-B2
Application numberUS-202017114211-A
CountryUS
Kind codeB2
Filing dateDec 7, 2020
Priority dateDec 16, 2019
Publication dateJul 11, 2023
Grant dateJul 11, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Multi-state engagement with continuous glucose monitoring (CGM) systems is described. Given the number of people that wear CGM systems and because CGM systems produce measurements continuously, a platform that provides a CGM system may have an enormous amount of data. This amount of data is practically, if not actually, impossible for humans to process. In implementations, a CGM platform includes a data analytics platform that obtains packages of glucose measurements provided by a CGM system and also obtains additional data associated with a user. The data analytics platform generates state information for the user by processing these CGM packages and the additional data, at least in part, by using one or more models. Based on this state information, the data analytics platform controls communication with the user, which may include generating intervention strategies to prevent users from transitioning to a negative state such as discontinuing use of the CGM system.

First claim

Opening claim text (preview).

What is claimed is: 1. A method comprising: obtaining continuous glucose monitoring (CGM) packages generated by a computing device based on glucose measurements provided by a CGM system worn by a user; obtaining additional data associated with the user, the additional data obtained from one or more sources different from the CGM system; generating one or more models based on historical CGM packages and historical additional data of a user population using one or more machine learning techniques; generating state information for the user by processing the CGM packages and the additional data, in part, using the one or more models, the state information including at least a current state of engagement of the user with the CGM system; and controlling communication with the user based on the state information, including sending notifications or messages to the computing device. 2. The method as described in claim 1 , wherein the current state of engagement of the user with the CGM system identified using the one or more models includes both a current role of the user and a current stage of a plurality of stages of interaction with the CGM system. 3. The method as described in claim 2 , wherein the current state of engagement of the user with the CGM system includes one of an active use stage, an erratic use stage, or a discontinued use stage. 4. The method as described in claim 2 , wherein the generating the state information further comprises generating probabilities that the user is in each of the plurality of stages of interaction with the CGM system, and wherein the current state is identified as the stage with the highest probability. 5. The method as described in claim 1 , wherein the generating the state information further comprises generating a transition probability that the user transitions from the current state to a new state by processing the CGM packages and the additional data using the one or more models. 6. The method as described in claim 5 , wherein the generating the state information further comprises determining one or more driving factors as likely to drive the transition of the user from the current state to the new state by processing the CGM packages and the additional data using the one or more models. 7. The method as described in claim 1 , wherein the CGM packages include the glucose measurements and characteristics of the glucose measurements, and the additional data describes characteristics of receipt by a CGM platform of the CGM package data. 8. The method as described in claim 1 , wherein the additional data comprises one or more of third party data, physiological data, socioeconomic data, attitudinal data, behavioral data, purchase history data, complaint data, or payment data. 9. A system comprising: a storage device configured to maintain at least continuous glucose monitoring (CGM) packages generated by a computing device based on glucose measurements provided by a CGM system worn by a user and additional data associated with the user; and a multi-state engagement system including a processor configured to: generate one or more models based on historical CGM packages and historical additional data of a user population using one or more machine learning techniques; generate state information for the user by processing the CGM packages and the additional data, in part, using the one or more models, the state information including at least a current state of engagement of the user with the CGM system; and control communication with the user based on the state information, including send notifications or messages to the computing device. 10. The system as described in claim 9 , wherein the current state of engagement of the user with the CGM system identified using the one or more models includes both a current role of the user and a current stage of a plurality of stages of interaction with the CGM system. 11. The system as described in claim 10 , wherein the current state of engagement of the user with the CGM system includes one of an active use stage, an erratic use stage, or a discontinued use stage. 12. The system as described in claim 10 , wherein the multi-state engagement system is further configured to generate the state information by generating probabilities that the user is in each of the plurality of stages of interaction with the CGM system, and wherein the current state is identified as the stage with the highest probability. 13. The system as described in claim 9 , wherein the multi-state engagement system is further configured to generate the state information by generating a transition probability that the user transitions from the current state to a new state by processing the CGM packages and the additional data using the one or more models. 14. The system as described in claim 13 , wherein the multi-state engagement system is further configured to generate the state information by determining one or more driving factors as likely to drive the transition of the user from the current state to the new state by processing the CGM packages and the additional data using the one or more models. 15. The system as described in claim 9 , wherein the CGM packages include the glucose measurements and characteristics of the glucose measurements, and the additional data describes characteristics of receipt by a CGM platform of the CGM package data. 16. The system as described in claim 9 , wherein the additional data comprises one or more of third party data, physiological data, socioeconomic data, attitudinal data, behavioral data, purchase history data, complaint data, or payment data. 17. One or more computer-readable storage media having instructions stored thereon that are executable by one or more processors to perform operations comprising: obtaining continuous glucose monitoring (CGM) packages generated by a computing device based on glucose measurements provided by a CGM system worn by a user; obtaining additional data associated with the user, the additional data obtained from one or more sources different from the CGM system; generating one or more models based on historical CGM packages and historical additional data of a user population using one or more machine learning techniques; generating state information for the user by processing the CGM packages and the additional data, in part, using the one or more models, the state information including at least a current state of engagement of the user with the CGM system; and controlling communication with the user based on the state information, including sending notifications or messages to the computing device. 18. The one or more computer-readable storage media as described in claim 17 , wherein the current state of engagement of the user with the CGM system identified using the one or more models includes both a current role of the user and a current stage of a plurality of stages of interaction with the CGM system. 19. The one or more computer-readable storage media as described in claim 18 , wherein the current state of engagement of the user with the CGM system includes one of an active use stage, an erratic use stage, or a discontinued use stage. 20. The one or more computer-readable storage media as described in claim 18 , wherein the generating the state information further comprises generating probabilities that the user is in each of the plurality of stages of interaction with the CGM system, and wherein the current state is identified as the stage with the highest probability. 21.

Assignees

Inventors

Classifications

  • characterised by the type of physiological signal transmitted · CPC title

  • Personality evaluation · CPC title

  • for calculating health indices; for individual health risk assessment · CPC title

  • Monitoring progression or stage of a disease · CPC title

  • for measuring glucose, e.g. by tissue impedance measurement · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11696706B2 cover?
Multi-state engagement with continuous glucose monitoring (CGM) systems is described. Given the number of people that wear CGM systems and because CGM systems produce measurements continuously, a platform that provides a CGM system may have an enormous amount of data. This amount of data is practically, if not actually, impossible for humans to process. In implementations, a CGM platform includ…
Who is the assignee on this patent?
Dexcom Inc
What technology area does this patent fall under?
Primary CPC classification A61B5/14532. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).